274 related articles for article (PubMed ID: 27548466)
1. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.
DeFilipp Z; Duarte RF; Snowden JA; Majhail NS; Greenfield DM; Miranda JL; Arat M; Baker KS; Burns LJ; Duncan CN; Gilleece M; Hale GA; Hamadani M; Hamilton BK; Hogan WJ; Hsu JW; Inamoto Y; Kamble RT; Lupo-Stanghellini MT; Malone AK; McCarthy P; Mohty M; Norkin M; Paplham P; Ramanathan M; Richart JM; Salooja N; Schouten HC; Schoemans H; Seber A; Steinberg A; Wirk BM; Wood WA; Battiwalla M; Flowers ME; Savani BN; Shaw BE
Bone Marrow Transplant; 2017 Feb; 52(2):173-182. PubMed ID: 27548466
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT.
DeFilipp Z; Duarte RF; Snowden JA; Majhail NS; Greenfield DM; Miranda JL; Arat M; Baker KS; Burns LJ; Duncan CN; Gilleece M; Hale GA; Hamadani M; Hamilton BK; Hogan WJ; Hsu JW; Inamoto Y; Kamble RT; Lupo-Stanghellini MT; Malone AK; McCarthy P; Mohty M; Norkin M; Paplham P; Ramanathan M; Richart JM; Salooja N; Schouten HC; Schoemans H; Seber A; Steinberg A; Wirk BM; Wood WA; Battiwalla M; Flowers MED; Savani BN; Shaw BE; ;
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1493-1503. PubMed ID: 27184625
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study.
Greenfield DM; Salooja N; Peczynski C; van der Werf S; Schoemans H; Hill K; Cortelezzi A; Lupo-Stangellini M; Özkurt ZN; Arat M; Metzner B; Turlure P; Rovo A; Socié G; Mohty M; Nagler A; Kröger N; Dreger P; Labopin M; Han TS; Tichelli A; Duarte R; Basak G; Snowden JA
Bone Marrow Transplant; 2021 Nov; 56(11):2820-2825. PubMed ID: 34274955
[TBL] [Abstract][Full Text] [Related]
4. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
Fulcher J; Blanchard AP; Bredeson C; van Walraven C
Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
[TBL] [Abstract][Full Text] [Related]
5. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
[TBL] [Abstract][Full Text] [Related]
6. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).
Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
Bone Marrow Transplant; 2006 Feb; 37(3):249-61. PubMed ID: 16435004
[TBL] [Abstract][Full Text] [Related]
7. Secondary solid cancer screening following hematopoietic cell transplantation.
Inamoto Y; Shah NN; Savani BN; Shaw BE; Abraham AA; Ahmed IA; Akpek G; Atsuta Y; Baker KS; Basak GW; Bitan M; DeFilipp Z; Gregory TK; Greinix HT; Hamadani M; Hamilton BK; Hayashi RJ; Jacobsohn DA; Kamble RT; Kasow KA; Khera N; Lazarus HM; Malone AK; Lupo-Stanghellini MT; Margossian SP; Muffly LS; Norkin M; Ramanathan M; Salooja N; Schoemans H; Wingard JR; Wirk B; Wood WA; Yong A; Duncan CN; Flowers ME; Majhail NS
Bone Marrow Transplant; 2015 Aug; 50(8):1013-23. PubMed ID: 25822223
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT.
Buchbinder D; Kelly DL; Duarte RF; Auletta JJ; Bhatt N; Byrne M; DeFilipp Z; Gabriel M; Mahindra A; Norkin M; Schoemans H; Shah AJ; Ahmed I; Atsuta Y; Basak GW; Beattie S; Bhella S; Bredeson C; Bunin N; Dalal J; Daly A; Gajewski J; Gale RP; Galvin J; Hamadani M; Hayashi RJ; Adekola K; Law J; Lee CJ; Liesveld J; Malone AK; Nagler A; Naik S; Nishihori T; Parsons SK; Scherwath A; Schofield HL; Soiffer R; Szer J; Twist I; Warwick AB; Wirk BM; Yi J; Battiwalla M; Flowers MDE; Savani B; Shaw BE
Bone Marrow Transplant; 2018 May; 53(5):535-555. PubMed ID: 29343837
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation.
Baker KS; Chow E; Steinberger J
Bone Marrow Transplant; 2012 May; 47(5):619-25. PubMed ID: 21643022
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.
Kelly DL; Buchbinder D; Duarte RF; Auletta JJ; Bhatt N; Byrne M; DeFilipp Z; Gabriel M; Mahindra A; Norkin M; Schoemans H; Shah AJ; Ahmed I; Atsuta Y; Basak GW; Beattie S; Bhella S; Bredeson C; Bunin N; Dalal J; Daly A; Gajewski J; Gale RP; Galvin J; Hamadani M; Hayashi RJ; Adekola K; Law J; Lee CJ; Liesveld J; Malone AK; Nagler A; Naik S; Nishihori T; Parsons SK; Scherwath A; Schofield HL; Soiffer R; Szer J; Twist I; Warwick A; Wirk BM; Yi J; Battiwalla M; Flowers ME; Savani B; Shaw BE
Biol Blood Marrow Transplant; 2018 Feb; 24(2):228-241. PubMed ID: 28939455
[TBL] [Abstract][Full Text] [Related]
11. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction.
Turcotte LM; Yingst A; Verneris MR
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1159-1166. PubMed ID: 27013015
[TBL] [Abstract][Full Text] [Related]
13. Impact of Hematopoietic Cell Transplantation on Cardiovascular Risk Factors and Insulin Sensitivity.
Ketterl TG; Chow EJ; Koves IH; Goodman P; Leisenring WM; Ballard S; Dengel DR; Moran A; Sinaiko AR; Steinberger J; Baker KS
Transplant Cell Ther; 2024 Feb; 30(2):243.e1-243.e13. PubMed ID: 37935316
[TBL] [Abstract][Full Text] [Related]
14. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients.
McClune BL; Polgreen LE; Burmeister LA; Blaes AH; Mulrooney DA; Burns LJ; Majhail NS
Bone Marrow Transplant; 2011 Jan; 46(1):1-9. PubMed ID: 20729922
[TBL] [Abstract][Full Text] [Related]
15. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.
Morton LM; Saber W; Baker KS; Barrett AJ; Bhatia S; Engels EA; Gadalla SM; Kleiner DE; Pavletic S; Burns LJ
Biol Blood Marrow Transplant; 2017 Mar; 23(3):367-378. PubMed ID: 27634019
[TBL] [Abstract][Full Text] [Related]
16. Type 2 Diabetes Mellitus, the Metabolic Syndrome, and Its Components in Adult Survivors of Acute Lymphoblastic Leukemia and Hematopoietic Stem Cell Transplantations.
Bielorai B; Pinhas-Hamiel O
Curr Diab Rep; 2018 Apr; 18(6):32. PubMed ID: 29671081
[TBL] [Abstract][Full Text] [Related]
17. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
[TBL] [Abstract][Full Text] [Related]
18. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Hematol Oncol Stem Cell Ther; 2012; 5(1):1-30. PubMed ID: 22446607
[TBL] [Abstract][Full Text] [Related]
19. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Bone Marrow Transplant; 2012 Mar; 47(3):337-41. PubMed ID: 22395764
[TBL] [Abstract][Full Text] [Related]
20. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Biol Blood Marrow Transplant; 2012 Mar; 18(3):348-71. PubMed ID: 22178693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
